Brief: Epigenomics AG Says Chief Executive Officer Greg Hamilton Is Resigning From Company And Executive Board Effective June 30, 2023
12/04/2023 18:58
April 12 (Reuters) - Epigenomics AG ECX1k.DE :
* SAYS CHIEF EXECUTIVE OFFICER GREG HAMILTON, IS RESIGNING
FROM
COMPANY AND EXECUTIVE BOARD EFFECTIVE JUNE 30, 2023
* DISCUSSIONS WILL ALSO BE INITIATED WITH OTHER MEMBERS OF
EXECUTIVE BOARD ABOUT FUTURE COMPOSITION OF EXECUTIVE BOARD
Source text for Eikon: ID:nEQ4VVMqYa
Further company coverage: ECX1k.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns